Anthropic has acquired Mithril Medicine, a one-person biotech company. The founder of Mithril Medicine utilized Anthropic's Claude AI to manage contracts, logistics, and experiments across eleven external laboratories. This AI-assisted approach accelerated the development of a muscular dystrophy treatment from concept to promising mouse trial results in under 18 months, with potential human trials slated for late 2028. AI
IMPACT Demonstrates AI's potential to accelerate drug discovery and development timelines.
RANK_REASON Acquisition of a company that used AI tools for its operations.
Read on Mastodon — mastodon.social →
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →